Autologous T regulatory cells: Phase II started

Caladrius began the double-blind, placebo-controlled, U.S. Phase II T-Rex Study trial to

Read the full 126 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE